We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+5.06%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$8.36B
AUM Growth
+$811M
Cap. Flow
+$513M
Cap. Flow %
6.13%
Top 10 Hldgs %
9.6%
Holding
2,400
New
687
Increased
686
Reduced
568
Closed
456

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.52%
2 Technology 13.89%
3 Financials 12.78%
4 Industrials 11.24%
5 Healthcare 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSP icon
1801
E.W. Scripps
SSP
$274M
$177K ﹤0.01%
10,746
-210
-2% -$3.04K
QUOT
1802
DELISTED
Quotient Technology Inc
QUOT
$177K ﹤0.01%
+11,400
New +$166K
LIND icon
1803
Lindblad Expeditions
LIND
$1.76B
$175K ﹤0.01%
11,769
-2,831
-19% -$40.1K
MNOV icon
1804
MediciNova
MNOV
$65M
$175K ﹤0.01%
+14,000
New +$141K
JCP
1805
DELISTED
J.C. Penney Company, Inc.
JCP
$175K ﹤0.01%
+105,442
New +$224K
RESI
1806
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$170K ﹤0.01%
+15,700
New +$175K
FLEX icon
1807
Flex
FLEX
$43.4B
$169K ﹤0.01%
17,088
-72,336
-81% -$757K
RDHL
1808
Redhill Biopharma
RDHL
$3.85M
$169K ﹤0.01%
+19
New +$155K
CSR
1809
Centerspace
CSR
$936M
$167K ﹤0.01%
2,800
+260
+10% +$14.3K
SBBP
1810
DELISTED
Strongbridge Biopharma plc.
SBBP
$166K ﹤0.01%
34,124
-22,361
-40% -$114K
PETX
1811
DELISTED
Aratana Therapeutics, Inc.
PETX
$165K ﹤0.01%
28,213
-10,236
-27% -$51.1K
ALTO icon
1812
Alto Ingredients
ALTO
$360M
$164K ﹤0.01%
86,304
+73,933
+598% +$165K
TWNK
1813
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$164K ﹤0.01%
+14,800
New +$189K
LFVN icon
1814
LifeVantage
LFVN
$82.4M
$163K ﹤0.01%
+14,808
New +$158K
TITN icon
1815
Titan Machinery
TITN
$466M
$163K ﹤0.01%
10,553
-8,720
-45% -$138K
FBM
1816
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$163K ﹤0.01%
+13,046
New +$183K
BNED icon
1817
Barnes & Noble Education
BNED
$412M
$162K ﹤0.01%
281
-118
-30% -$66.8K
MPT
1818
Medical Properties Trust
MPT
$2.89B
$162K ﹤0.01%
10,868
-42,309
-80% -$617K
ZVO
1819
DELISTED
Zovio Inc. Common Stock
ZVO
$162K ﹤0.01%
15,900
-3,716
-19% -$39.2K
ALDX icon
1820
Aldeyra Therapeutics
ALDX
$91.7M
$161K ﹤0.01%
+11,700
New +$94.9K
KRNY icon
1821
Kearny Financial
KRNY
$592M
$160K ﹤0.01%
11,586
-25,180
-68% -$346K
RFL icon
1822
Rafael Holdings
RFL
$111M
$160K ﹤0.01%
+19,266
New +$176K
VBIV
1823
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$160K ﹤0.01%
2,198
+1,682
+326% +$111K
RYZ
1824
Ryerson Holding Corp
RYZ
$1.6B
$158K ﹤0.01%
14,007
-378
-3% -$4.25K
CLCT
1825
DELISTED
Collectors Universe
CLCT
$157K ﹤0.01%
+10,600
New +$149K

Similar funds

Squarepoint's Q3 2018 Portfolio in Review

As of Q3 2018, Squarepoint held 2,400 positions worth $8.36B, up 11% from $7.55B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Squarepoint deployed $513M of net new capital in Q3 2018, opening 687 new positions and adding to 686 existing holdings. Its largest new stake was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Cigna, an estimated $69.1M trimmed.

  • Squarepoint's largest Q3 2018 buy was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.
  • Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q3 2018, an estimated $58.8M increase.
  • Squarepoint's biggest Q3 2018 reduction was Cigna, cutting an estimated $69.1M.
  • Squarepoint fully exited Vanguard FTSE Emerging Markets ETF in Q3 2018, selling an estimated $79.7M.
  • Squarepoint's ten largest holdings make up 9.6% of its $8.36B portfolio in Q3 2018.
  • Squarepoint opened 687 new positions and closed 456 in Q3 2018.
  • Squarepoint's portfolio value rose 11% quarter-over-quarter to $8.36B.

Based on Squarepoint's 13F filing for Q3 2018, filed 14 Nov 2018.